Stock Earnings

Question 1

Quels sont les états financiers clés de Novo Nordisk A/S ?

Accepted Answer

Selon le dernier état financier (Form-10K), Novo Nordisk A/S a un total d'actifs de $465,795, un bénéfice net profit de $100,988

Question 2

Quels sont les ratios financiers clés pour NONOF ?

Accepted Answer

Le ratio de liquidité de Novo Nordisk A/S est 1.44, la marge nette est 34.77, les ventes par action sont de $65.06.

Question 3

Comment les revenus de Novo Nordisk A/S sont-ils répartis par segment ou géographie ?

Accepted Answer

Novo Nordisk A/S largest revenue segment is Victoza, at a revenue of 5,482,000,000 in the most earnings release.For geography, US Revenue is the primary market for Novo Nordisk A/S, at a revenue of 167,404,000,000.

Question 4

Novo Nordisk A/S est-elle rentable ?

Accepted Answer

yes, selon les derniers états financiers, Novo Nordisk A/S a un bénéfice net profit de $100,988

Question 5

Novo Nordisk A/S a-t-elle des passifs ?

Accepted Answer

yes, Novo Nordisk A/S a un passif de 322,309

Question 6

Combien d'actions en circulation Novo Nordisk A/S a-t-elle ?

Accepted Answer

Novo Nordisk A/S a un total d'actions en circulation de 4,441

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	315,603	290,403	232,261	176,954	140,800	126,946
Revenue Growth (YoY)	17%	25%	31%	26%	11%	4%
Cost of Revenue	56,664	43,560	35,765	28,448	23,658	20,932
Gross Profit	258,939	246,843	196,496	148,506	117,142	106,014
Selling, General & Admin	73,122	66,546	60,767	49,932	40,409	36,108
Research & Development	51,193	38,021	29,373	21,761	16,292	13,713
Operating Expenses	126,280	107,942	91,798	72,837	57,784	51,411
Other Non Operating Income (Expenses)	--	-289	-197	-181	-122	-150
Pretax Income	131,912	127,191	104,674	69,062	59,080	53,130
Income Tax Expense	28,139	26,203	20,991	13,537	11,323	10,992
Net Income	103,773	100,988	83,683	55,525	47,757	42,138
Net Income Growth	10%	21%	51%	16%	13%	8%
Shares Outstanding (Diluted)	4,446.8	4,463	4,494.8	4,544.6	4,606.2	4,680
Shares Change (YoY)	0%	-1%	-1%	-1%	-2%	-2%
EPS (Diluted)	23.33	22.63	18.62	12.22	10.37	9
EPS Growth	10%	22%	52%	18%	15%	10%
Free Cash Flow	60,950	69,659	70,012	64,134	47,615	29,870
Free Cash Flow Per Share	13.7	15.6	15.57	14.11	10.33	6.38
Gross Margin	82.04%	85%	84.6%	83.92%	83.19%	83.51%
Operating Margin	42.03%	47.83%	45.07%	42.76%	42.15%	43.01%
Profit Margin	32.88%	34.77%	36.02%	31.37%	33.91%	33.19%
Free Cash Flow Margin	19.31%	23.98%	30.14%	36.24%	33.81%	23.52%
EBITDA	154,277	158,008	114,111	83,031	65,383	60,356
EBITDA Margin	48.88%	54.4%	49.13%	46.92%	46.43%	47.54%
D&A For EBITDA	21,618	19,107	9,413	7,362	6,025	5,753
EBIT	132,659	138,901	104,698	75,669	59,358	54,603
EBIT Margin	42.03%	47.83%	45.07%	42.76%	42.15%	43.01%
Effective Tax Rate	21.33%	20.6%	20.05%	19.6%	19.16%	20.68%

Novo Nordisk A/S (NONOF) Price

NONOF Stock Price Chart

NONOF Income

Follow-Up Questions